Latest News about Hal Barron
Recent news which mentions Hal Barron
Lilly jumps in with Vir, GSK on antibody drug combo against Covid
January 27, 2021
From Business Journals
GlaxoSmithKline, Vir Biotechnology begin late-stage testing of experimental Covid-19 therapy
August 31, 2020
From Business Journals
From Business Journals
From Business Journals
GlaxoSmithKline teams with Vir Biotechnology to develop coronavirus vaccine, treatments
April 06, 2020
From Business Journals
Longtime Genentech exec retiring as new CEO settles in
August 19, 2019
From Business Journals
GSK layoffs focused on PA and U.K. sites – not Triangle
April 19, 2019
From Business Journals
GSK cuts employees at its R&D unit in Collegeville
April 19, 2019
From Business Journals
$4.2B deal: GSK and Merck KGaA to develop cancer immunotherapy
February 05, 2019
From Business Journals
Federal shutdown cancels conference aimed at health care cooperation
January 04, 2019
From Business Journals
Waltham's Tesaro to be acquired by GlaxoSmithKline for $5.1B
December 03, 2018
From Business Journals
$5.1B deal: GSK to buy Boston-area cancer drug developer
December 03, 2018
Tickers
GSK
From Business Journals
Tickers
GSK
From Business Journals
GlaxoSmithKline R&D leader departing for UK government job
November 08, 2017
Tickers
GSK
From Business Journals
Art Levinson's Google-backed aging research company Calico is hiring
December 01, 2014
Tickers
ABBV
From Business Journals
Google's Calico inks deal around neurodegenerative diseases
September 11, 2014
Tickers
ABBV
From Business Journals
Calico, AbbVie look at $1.5 billion partnership on age-related diseases
September 03, 2014
From Business Journals
Stanford researchers hope plasma injections from the young will rejuvenate Alzheimer's patients
May 05, 2014
From Business Journals
Young blood: Stanford researchers hope plasma injections from the young rejuvenate Alzheimer's patients
May 04, 2014
From Business Journals
From Business Journals
Genentech scores FDA approval for new leukemia drug
November 01, 2013
Tickers
RHHVF
From Business Journals
Genentech's Perjeta wins FDA OK with new approach to breast cancer
September 30, 2013
Tickers
RHHVF
From Business Journals
Tickers
RHHVF
From Business Journals
Tickers
RHHVF
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.